A clinical study investigated whether telomere length is associated with the severity of COVID-19. Telomeres protect the ends of chromosomes and shorten over the course of a lifetime. They are therefore considered a biological marker associated with, among other things, cellular aging and regenerative capacity.
What was investigated in the study?
Hospitalized patients with COVID-19 were examined. For the participants, telomere length in blood cells was determined and then compared with the respective course of the disease.
The researchers analyzed whether differences in telomere length were associated with clinical features such as longer hospital stays, intensive care, or mechanical ventilation.
What results were observed?
In the study, individuals with shorter telomeres more frequently experienced a more severe course of COVID-19.
The observed association remained even after factors such as age, sex, lifestyle, and pre-existing conditions were statistically accounted for.
The study thus provides evidence that telomere length could offer additional information about a person's biological resilience that goes beyond chronological age.
How can the results be explained?
Telomeres play a role in the ability of cells to divide and renew themselves. This regenerative capacity is particularly important for the immune system.
Shorter telomeres could therefore be linked to a reduced capacity of certain immune cells to respond to major stressors such as a viral infection. However, it cannot be concluded from this that short telomeres alone cause a severe course of disease.
How should the results be interpreted?
The study shows an association between telomere length and the severity of COVID-19. However, it does not prove a direct cause-and-effect relationship.
The course of COVID-19 is influenced by numerous factors. Telomere length should therefore be viewed as a potential biological marker within a complex interplay.
Further studies are required to clarify what significance telomere length might have for individual susceptibility to disease and the progression of viral infections.
The full study and further details on study design, telomere measurement, and disease progression can be found in the original publication.
To the scientific publication →
Further research on COVID-19 and biological aging
Other investigations are looking into changes in telomere length following a COVID-19 infection as well as epigenetic markers of biological aging.
Telomere length after COVID-19: Results of a cohort study →
COVID-19 and biological aging: Results of an epigenetic study →
